v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating expenses:    
Research and development $ 669 $ 5,371
General and administrative 5,349 9,109
Restructuring and impairment charges 992 16,082
Total operating expenses 7,010 30,562
Loss from operations (7,010) (30,562)
Interest income 678 1,175
Interest expense (1,552) (1,098)
Other rental income 2,242 2,242
Gain on contract termination 1,620 0
Other (expense) income, net (182) 43
Net loss (4,204) (28,200)
Other comprehensive loss:    
Foreign currency translation 131 (159)
Unrealized loss on available-for-sale securities, net (80) (64)
Net comprehensive loss $ (4,153) $ (28,423)
Net loss per share, basic (in dollars per share) $ (0.62) $ (4.32)
Net loss per share, diluted (in dollars per share) $ (0.62) $ (4.32)
Weighted-average shares used in computing net loss per share, basic (in shares) 6,781,976 6,532,658
Weighted-average shares used in computing net loss per share, diluted (in shares) 6,781,976 6,532,658